SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
BIOTECH: Firm Finds Unusual Way to Spread Word on Sleep Disorders
ResMed Inc. has partnered with the San Diego History Center to create The Science of Sweet Dreams exhibit showcased in Balboa Park this spring.
The San Diego Business Journal invited the leaders of the region’s six major health care organizations to answer the following question: What one thing do you do every day that contributes to the success of your health system?
BIOTECH: Medical Device Companies Change Care Models and Lives With Breakthroughs
Medical devices often play second fiddle to the more glamorous blockbuster drugs, rarely earning the spotlight for major medical breakthroughs. But they include genuine miracles of modern medicine: pacemakers, artificial joints, replacement heart valves, scanners, and radiotherapy machines.
BIOTECH: Illumina’s New Machine Does Actual Detective Work
llumina Inc. has developed a technology that could transform the work done by crime scene investigators, helping to solve cold cases by uncovering the information hidden in degraded DNA.
Conatus Pharmaceuticals Inc. plans to hold a follow-on stock offering, the developer of liver disease drugs said Thursday.
San Diego-based GlySens Inc. has appointed William Markle as the company's new president and CEO.
Alex Lukianov has resigned as chief executive officer and chairman of the board at NuVasive, Inc. for reportedly violating company policies regarding reimbursement and personnel.
Tri-City Medical Center announced the appointment of Kirkpatrick “Kapua” Conley as chief operating officer.
San Diego-based Otonomy Inc., a company that makes treatments for the middle and inner ear, announced the appointment of Dr. Dean Hakanson as chief medical officer.
Sorrento Therapeutics Inc. announced the appointment of George Ng to the position of executive vice president and chief legal officer.
San Diego-based aTyr Pharma Inc., a biotherapeutics firm that treats diseases of the immune system, announced the completion of a $76 million Series E financing on Tuesday.
Orexigen Therapeutics Inc. has hired Tom Cannell has as its chief commercial officer, according to a recent news release.
Teva Pharmaceutical Industries Ltd. is buying San Diego-based Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on treatments for central nervous system conditions, according to a recent news release.
As Faheem Hasnain walks me through rooms of glass and metal, I can’t help but compare the Receptos headquarters to pictures I’ve seen of the Google complex. Pingpong tables and shuffleboard tournaments are held frequently in the biotech’s break-room, and a king-sized chalkboard stands in the corner with winners and losers scratched in white chalk.